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Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder in which complex genetic factors play an
important role. Several strains of gene-targeted mice have been reported to develop SLE, implicating the null genes in
the causation of disease. However, hybrid strains between 129 and C57BL/6 mice, widely used in the generation of
gene-targeted mice, develop spontaneous autoimmunity. Furthermore, the genetic background markedly influences
the autoimmune phenotype of SLE in gene-targeted mice. This suggests an important role in the expression of
autoimmunity of as-yet-uncharacterised background genes originating from these parental mouse strains. Using
genome-wide linkage analysis, we identified several susceptibility loci, derived from 129 and C57BL/6 mice, mapped in
the lupus-prone hybrid (129 3 C57BL/6) model. By creating a C57BL/6 congenic strain carrying a 129-derived
Chromosome 1 segment, we found that this 129 interval was sufficient to mediate the loss of tolerance to nuclear
antigens, which had previously been attributed to a disrupted gene. These results demonstrate important epistatic
modifiers of autoimmunity in 129 and C57BL/6 mouse strains, widely used in gene targeting. These background gene
influences may account for some, or even all, of the autoimmune traits described in some gene-targeted models of SLE.
Citation: Bygrave AE, Rose KL, Cortes-Hernandez J, Warren J, Rigby RJ, et al. (2004) Spontaneous autoimmunity in 129 and C57BL/6 mice—Implications for autoimmunity
described in gene-targeted mice. PLoS Biol 2(8): e243.
Introduction
Systemic lupus erythematosus (SLE) is a chronic auto-
immune disease characterised by the production of autoanti-
bodies (auto-Abs) against a wide spectrum of self-antigens,
mainly from subcellular compartments, especially the cell
nucleus. Genetic predisposition is an important contributor
to susceptibility to SLE in both humans and animals (Vyse
and Todd 1996; Harley et al. 1998; Theoﬁlopoulos and Kono
1999; Wakeland et al. 2001). Genes in multiple pathways
participate in mediating disease pathogenesis, and epistatic
interactions amongst these genes inﬂuence the expression of
disease. In this context, both genetic linkage studies in
spontaneous lupus-prone models and synthetic murine
models of autoimmunity generated by targeted disruption
of speciﬁc genes modulating the immune system have widely
been used to investigate the complexity of SLE.
The best-studied strains of mice that spontaneously
develop a lupus-like pathology are the New Zealand Black/
New Zealand White hybrid strain (NZB/WF1); the MRL/Mp lpr/
lpr strain, which carries the lpr mutation of the FAS receptor
gene; and the BXSB strain, which carries the Y chromosome
autoimmune accelerator (Yaa) gene (Theoﬁlopoulos and
Dixon 1985). Extensive genetic mapping studies in all three
strains have identiﬁed multiple intervals associated with
disease susceptibility. Interestingly, the majority of the
intervals detected are strain-speciﬁc, conﬁrming the genetic
complexity of the disease and indicating the presence of
extensive heterogeneity in the genes contributing to the
pathogenesis of the disease. However, some susceptibility loci
have been mapped to similar chromosome locations in
different strains, suggesting that at least some susceptibility
may be shared amongst lupus-prone strains. Amongst these
shared susceptibility loci, the most striking are loci on distal
Chromosome 1, for which important contributing genes have
been found in New Zealand and BXSB models (Theoﬁlopou-
los and Kono 1999; Wakeland et al. 2001).
Although considerable efforts have been made to identify
the genes responsible for the development of the disease, with
the exception of the lpr mutation, none of the genetic
contributions to disease in the three well-documented
murine SLE strains have yet been fully resolved at the
molecular or protein level. Thus, targeted genetic disruption
of candidate genes encoding proteins of the immune system
has been extensively used to examine their role in immune
regulation. However, the most surprising result of this
powerful approach has been the high frequency with which
such mutations have been associated with an autoimmune
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Open access, freely available online PLoS BIOLOGYphenotype. In this regard, it is of note that hybrid strains
between 129 and C57BL/6 mice, widely used in the generation
of gene-targeted mice, are spontaneously predisposed to
development of humoral autoimmunity with low levels of
glomerulonephritis (Obata et al. 1979; Botto et al. 1998;
Bickerstaff et al. 1999; Santiago-Raber et al. 2001). Further-
more, the genetic background markedly inﬂuences the
autoimmune phenotype in gene-targeted mice (Bolland and
Ravetch 2000; Santiago-Raber et al. 2001; Mitchell et al. 2002).
These observations led to the hypothesis that the auto-
immune phenotype described in some gene-targeted mice
might be due primarily to combinations of as-yet-uncharac-
terised background genes, originating from 129 and C57BL/6
mice strains, interacting or not with the mutated allele. To
test this, we conducted a genome-wide scan analysis of two
large cohorts of (1293C57BL/6)F2 mice, one of which carried
a mutation in the serum amyloid P component gene (Apcs).
The Apcs-deﬁcient mice (Apcs
 / ) were chosen as an example
of a gene-targeted strain previously reported to develop a
lupus-like disease on the hybrid genetic background (129 3
C57BL/6); autoimmunity in Apcs
 /  mice persists even after
backcrossing the mutated gene onto C57BL/6 (Bickerstaff et
al. 1999). We chose this targeted gene in particular to study
since the Apcs gene is located on Chromosome 1, approx-
imately 94 cM from the centromere, within a region where
several lupus-susceptibility loci, designated Sle1 (Morel et al.
2001), Nba2 (Drake et al. 1995; Vyse et al. 1997), and Bxs3
(Hogarth et al. 1998; Haywood et al. 2000), have been mapped
in NZW, NZB, and BXSB lupus-prone strains, respectively.
This region contains several genes, including those encoding
FccRII, the complement receptor CR1/2 (CD35/CD21), and
the decay-accelerating factor CD55 (Prodeus et al. 1998;
Bolland and Ravetch 2000; Miwa et al. 2002; Wu et al. 2002),
which have each been implicated in the causation of SLE
when inactivated by gene-targeting in 129 embryonic stem
cells.
Here we show that there are multiple genetic loci, derived
from both 129 and C57BL/6 mice, contributing to auto-
immunity. Furthermore, a 129-derived interval on distal
Chromosome 1, when transferred onto the C57BL/6 genome,
a combination commonly created by backcrossing onto
C57BL/6 a gene that has been inactivated in 129 embryonic
stem cells, was sufﬁcient to cause humoral autoimmunity in
its own right, irrespective of the presence of the mutated Apcs
gene. These results demonstrate important epistatic inter-
actions between genes from 129 and C57BL/6 genomes on the
development of autoimmunity and illustrate the important
effects of background genes in the analysis and interpretation
of autoimmune phenotypes associated with targeted genetic
disruptions.
Results
Disease Traits in (129 3 C57BL/6)F2 and (129 3 C57BL/
6)F2.Apcs
 /  Mice
To investigate the genetic basis of the lupus-like disease
observed in the (129 3 C57BL/6) hybrid mice, we generated
two large cohorts of (1293C57BL/6)F2 animals, one carrying
a mutation in the Apcs gene, and monitored them for 1 y
under identical environmental conditions. Since female mice
in the original reports showed a higher penetrance of disease,
the present study was conducted only on female mice. The
results of the phenotypic analysis at 1 y of age are summarised
in Tables 1 and 2. As previously reported (Botto et al. 1998),
the wild-type (129 3 C57BL/6)F2 mice developed lupus traits
with elevated levels of auto-Abs, starting from 6 mo of age
(data not shown), and histological evidence of proliferative
glomerulonephritis. In agreement with our previous obser-
vations (Bickerstaff et al. 1999), the titres of anti-nuclear Abs
(ANAs) and anti-chromatin Ab were considerably greater in
the (1293C57BL/6)F2.Apcs
 /  mice compared with the strain-
matched controls. However, in contrast to our original
ﬁndings, the levels of the other two disease serological
markers analysed (anti-single-stranded DNA [ssDNA] and
anti-double-stranded DNA [dsDNA] Abs) and the severity of
the renal pathology were not different between the two
experimental groups. In view of the possibility of an
association between the ﬁxed 129-derived segment ﬂanking
the mutated Apcs gene and the autoimmune traits observed,
the genome-wide linkage analysis of the two experimental
cohorts was carried out separately.
Mapping of Loci Predisposing to Lupus in the Hybrid
Strain (129 3 C57BL/6)
Mice were genotyped with 143 microsatellite markers
distributed throughout the autosomes such that 98% of the
genes were within 20 cM of an informative marker. A
summary of the genome-wide linkage analysis for each of
the disease traits measured is shown in Table 3. The areas of
linkage were deﬁned according to the parental origin, 129 or
C57BL/6. Only linkages identiﬁed in both experimental
groups are reported in Table 3, with the exception of the
Chromosome 1 distal segment, where the linkage analysis
Table 1. Spontaneous Auto-Abs in Apcs
 /  and Wild-Type (129 3 C57BL/6)F2 Female Mice
(129 3 C57BL/6)F2 (129 3 C57BL/6)F2.Apcs
 / 
Disease Marker No Median Range No Median Range p Value
ANA 140 80 0–20,480 158 320 0–20,480 0.0036
Anti-ssDNA Ab 139 25 1–3,500 158 29 1–3,500 NS
Anti-dsDNA Ab 140 0 0–5,120 158 0 0–10,240 NS
Anti-Chromatin Ab 137 1,090 1–1.9 3 10
6 158 3,657 1–1.6 3 10
6 0.0005
Significant differences between Apcs
 /  and wild-type controls by Mann–Whitney U test. The numbers tested for different phenotypes are not equal due to the limited
amount of serum or death of the mice before the end of the experiment. NS, not significant.
DOI: 10.1371/journal.pbio.0020243.t001
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Gene-Targeted Mice and Autoimmunitycould not be applied to the (1293C57BL/6)F2.Apcs
 /  mice as
this region was of ﬁxed 129 origin. Chromosomes where
linkages were present only in one of the two cohorts are
shown in Figures 1–3.
The quantitative trait linkage (QTL) analysis identiﬁed
several intervals on Chromosome 1 with linkage to disease
serological markers, and these regions were all derived from
t h e1 2 9m o u s es t r a i n( s e eT a b l e3 ;F i g u r e s4a n d5 ) .
Interestingly, whilst ANA and anti-chromatin Ab levels
showed suggestive or signiﬁcant linkages only to the
telomeric region of Chromosome 1, with an estimated peak
occurring at a position approximately 90 cM near the Apcs
gene, anti-dsDNA or anti-ssDNA Ab production was also
linked to other segments on Chromosome 1, indicating a
more complex genetic contribution from the 129 mouse
strain.
Guided by these observations, we investigated whether the
Table 3. Summary of Genome-Wide Linkage Analysis in Apcs
 /  and Wild-Type (129 3 C57BL/6)F2 Female Mice


























1 D1Mit105 80 95.8 7.5310
 5b 1 N/A N/A N/A N/A 129 N/A
D1Mit17 105.7 (4.1)
ANA
3 D3Mit40 39.7 50.4 3.3310
 6c 3 D3Mit40 39.7 44.8 0.014 B6 4.6310
 8c
D3Mit13 61.8 (5.4) D3Mit103 51.1 (1.8)
1 D1Mit3 11 16.8 5.5310
 3a 1 D1Mit3 11 16 1.1310
 3a 129 6310
 6c
D1Mit213 25.7 (2.2) D1Mit213 25.7 (2.9)
Anti-dsDNA Ab 1 D1Mit139 65 76.7 6.4310
 4a 1 N/A N/A N/A N/A 129 N/A
D1Mit105 80 (3.2)
1 D1Mit105 80 92.3 7.1310
 4a 1 N/A N/A N/A N/A 129 N/A
D1Mit115 99.7 (3.1)
1 D1Mit83 52 87.9 9.1310
 4a 1 N/A N/A N/A N/A 129 N/A
D1Mit115 99.7 (3.0)
Anti-chromatinAb
3 D3Mit278 33.7 34.7 0.016 (1.8) 3 D3Mit278 33.7 44 3.6310
 3a B6 5.9310
 5b
D3Mit13 61.8 51.1 0.012 (1.8) D3Mit103 51.1 (2.4)
1 D1Mit123 21 50–60 1.2310
 4b 1 D1Mit123 21 35.9 1310
 3a 129 1310
 7c
D1Mit139 65 (3.9) D1Mit139 65 (2.9)
Anti-ssDNA Ab 1 D1Mit139 65 75.5 9310
 6c(5.0) 1 N/A N/A N/A N/A 129 N/A
D1Mit17 105 86.3 2310
 6c(5.6)
3 D3Mit40 39.7 55.1 0.012 3 D3Mit40 39.7 47.9 0.021 B6 2.5310
 4a
D3Mit258 70.3 (1.9) D3Mit258 70.3 (1.7)
a Suggestive linkage.
b Significant linkage.
c Highly significant linkage as defined in the material and method section.
Chr, Chromosome; Est. Peak, Estimated Peak; LOD, logarithm of odds; N/A, not applicable.
Chromosomes where linkages were not present in both experimental groups are not illustrated. See Materials and Methods for details. The oligonucleotide sequences and
approximate positions of the microsatellite markers used were taken from the Mouse Genome Database, Mouse Genome Informatics, Jackson Laboratory, Bar Harbor, Maine,
United States (http://www.informatics.jax.org).
DOI: 10.1371/journal.pbio.0020243.t003
Table 2. Histological Assessment of Kidney Sections in Apcs
 / 
and Wild-Type (129 3 C57BL/6)F2 Female Mice
Grade of Glomerulonephritis
Mouse Strain No 0 1 2 3
(129 3 C57BL/6)F2 141 110 25 4 2
(129 3 C57BL/6)F2.Apcs
 /  157 134 19 2 2
The renal sections were scored on a 0–3 scale on the intensity and extent of the
histopathological changes as described in Materials and Methods. The difference
between the two experimental groups was not significant.
DOI: 10.1371/journal.pbio.0020243.t002
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Gene-Targeted Mice and Autoimmunityincreased levels of ANA and anti-chromatin Ab observed in
the Apcs
 /  mice were caused by a gene(s) within the ﬁxed 129
region surrounding the mutated Apcs gene, rather than
caused by the mutated Apcs gene itself. We compared the
levels of these auto-Abs between all (1293C57BL/6)F2.Apcs
 / 
mice and a group of 33 wild-type mice that were selected for
being homozygous 129 in the region of Chromosome 1
between microsatellites D1Mit105 and D1Mit 223 (80–106
cM) (Figure 6A–6D). In contrast to the results reported in
Table 1, this comparison showed no signiﬁcant differences
between the two experimental groups. This result demon-
strates that, most likely, the 129-derived region and not the
lack of Apcs was mediating the production of ANA and anti-
chromatin Ab. Consistent with this explanation, we found
that the 129 mice have signiﬁcantly higher levels of Apcs in
circulation compared with the C57BL/6 mice (median, 83 mg/l;
range, 25–208; n = 16 versus median, 5 mg/l; range, 4–9; n =
10, respectively; p , 0.0001). The C57BL/6 strain has
previously been reported to be one of the murine strains
deﬁned as low Apcs producers (Pepys et al. 1979; Baltz et al.
1980). In addition, sequence analysis of the entire Apcs coding
region in both strains failed to identify any coding sequence
polymorphisms in the Apcs gene (data not shown), indicating
that a structural variant of the protein is unlikely to be the
explanation for our ﬁndings. This is consistent with a
previous report by Drake et al. (1996) that showed no Apcs
Figure 1. Linkage of Chromosome 2 with ANA and Anti-Chromatin Abs
in (129 3 C57BL/6)F2.Apcs
 /  Mice
These associations were not detected in (129 3 C57BL/6)F2 animals.
Centimorgan positions were deduced by interval mapping, anchoring
marker locations to data from http://www.informatics.jax.org. Dotted
lines and the dashed line indicate the threshold over which linkages
were considered suggestive or signiﬁcant, respectively, as deﬁned in
Materials and Methods.
DOI: 10.1371/journal.pbio.0020243.g001
Figure 2. Linkage of Chromosome 8 with Anti-Chromatin and Anti-
dsDNA Abs in (129 3 C57BL/6)F2 Mice
These linkages were not detected in (129 3 C57BL/6)F2.Apcs
 / 
animals. Centimorgan positions were deduced by interval mapping,
anchoring marker locations to data from http://www.informatics.jax.
org. Dotted lines indicate the threshold over which linkage was
considered suggestive, as deﬁned in Materials and Methods.
DOI: 10.1371/journal.pbio.0020243.g002
Figure 3. Linkage of Chromosome 4 with Anti-dsDNA Abs
The estimated peak in (129 3 C57BL/6)F2 mice was at position 51.3
cM, whilst in the (129 3 C57BL/6)F2.Apcs
 / animals it was was at
position 71 cM, indicating that most likely these were two
independent loci. Centimorgan positions were deduced by interval
mapping, anchoring marker locations to data from http://www.
informatics.jax.org. Dotted lines the indicate threshold over which
linkage was considered suggestive, as deﬁned in Materials and
Methods.
DOI: 10.1371/journal.pbio.0020243.g003
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Gene-Targeted Mice and Autoimmunitycoding sequence differences amongst several autoimmune
and nonautoimmune murine strains.
In addition to the 129-derived segments, in both cohorts
the C57BL/6 strain contributed to the autoimmune traits with
one major susceptibility locus on Chromosome 3. A genomic
region between D3Mit40 and D3Mit13, with an estimated
peak at position approximately 51 cM, showed a signiﬁcant
linkage to ANA production and weaker linkages to anti-
ssDNA and anti-chromatin production (see Table 3; Figure 7).
The high frequency of autoimmune phenotype in the (129 3
C57BL/6) hybrid genetic background and its absence in either
of the inbred parental strains imply that there are essential
interactions between 129- and C57BL/6-derived alleles for the
expression of autoimmunity. We investigated further the
effects of genes from the C57BL/6 background by repeating
the linkage analysis in (129 3 C57BL/6)F2 mice, whilst
controlling for the very strong 129 effect on distal Chromo-
some 1, as previously described (Zeng 1994). The results of
this analysis showed that the statistical support for the linkage
of the C57BL/6 locus on Chromosome 3 for ANA increased
from logarithm of odds (LOD) 5.4 to LOD 6.4.
In contrast to these strong associations with disease
serological markers, the QTL analysis identiﬁed only two
potential linkages to glomerulonephritis: one in the wild-type
mice on Chromosome 7 across a 10 cM region between
D7Mit246 (15 cM) and D7Mit145 (26.5 cM) of 129 origin (LOD
2.86, p = 0.0013), and one on Chromosome 17 between
D17Mit100 (11.7 cM) and D17Mit216 (29.4 cM) from the
C57BL/6 strain (LOD 1.3, p = 0.049 and LOD 1.67, p = 0.021
in the wild-type and Apcs
 /  mice, respectively). Histological
evidence of glomerulonephritis was only found in approx-
imately 20% of the mice in each cohort, which reduces the
power of the QTL analysis for this disease trait.
Production of a C57BL/6.129 Chromosome 1 Congenic
Line and Its Phenotypic Analysis
We generated a C57BL/6 congenic line carrying the
telomeric region of Chromosome 1 from the 129 mouse
strain, in order to dissect the complex polygenic disease
phenotype of the (C57BL/6 3 129/Sv)F2 hybrid strain into its
individual genetic components. The 129 interval was back-
crossed seven times onto C57BL/6, and at each generation the
presence or absence of the Chromosome 1 interval was
determined with several microsatellite markers. Each back-
crossed generation was screened with more than three
markers per chromosome to facilitate the removal of
unselected 129 genomic regions. At the end of the back-
crossing, the 129-derived Chromosome 1 interval in the
congenic mice extended from microsatellite marker
D1Mit105 to D1Mit223 (80–106 cM), which encompasses the
Figure 4. Interval Mapping Scans Showing QTL on Chromosome 1 with
Anti-dsDNA and Anti-ssDNA Abs
Centimorgan positions were deduced by interval mapping, anchoring
marker locations to data from http://www.informatics.jax.org. Dotted
lines indicate the threshold over which linkage was considered
suggestive, dashed lines indicate the threshold over which linkage was
considered signiﬁcant, and dotted/dashed lines indicate highly
signiﬁcant linkage, as deﬁned in Materials and Methods. See Table
3 for additional details.
DOI: 10.1371/journal.pbio.0020243.g004
Figure 5. Interval Mapping Scans Showing QTL on Chromosome 1 with
ANA and Anti-Chromatin Abs
Centimorgan positions were deduced by interval mapping, anchoring
marker locations to data from http://www.informatics.jax.org. Dotted
lines indicate the threshold over which linkage was considered
suggestive, and dashed lines indicate the threshold over which linkage
was considered signiﬁcant, as deﬁned in Materials and Methods. See
Table 3 for additional details.
DOI: 10.1371/journal.pbio.0020243.g005
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Gene-Targeted Mice and Autoimmunitymost important 129 interval identiﬁed by the linkage studies
in the (C57BL/6 3 129/Sv)F2 mice.
Female Chromosome 1 congenic mice (C57BL/
6.129[D1Mit105–223]), together with sex-matched Apcs
 / 
mice backcrossed onto C57BL/6 for ten generations (C57BL/
6.Apcs
 / ) and C57BL/6 controls, were monitored for the
presence of lupus. In the C57BL/6.Apcs
 /  mice, the 129
genome around the Apcs locus was mapped as a stretch of
approximately 17 cM, positioned from 87.9 cM (D1Mit15) to
105 cM (D1Mit17). Thus, the congenic line carried a similar
129 region (80–106 cM) to the one present in the C57BL/
6.Apcs
 /  mice (87.9–105 cM). At 1 y of age, all animals were
sacriﬁced, the auto-Abs assessed, and the renal histology
examined. The results of this analysis are shown in Figure 8.
As previously reported (Bickerstaff et al. 1999), the levels of
auto-Abs were markedly increased in the C57BL/6.Apcs
 / 
compared to the wild-type C57BL/6 controls. However, the
C57BL/6.129(D1Mit105–223) animals also expressed high
levels of auto-Abs, and these titres were not different from
those detected in the matched congenic mice containing a
null mutation of the Apcs gene. These results clearly
demonstrated that epistatic interactions between 129 loci
on Chromosome 1 and C57BL/6 genes were sufﬁcient to
mediate the loss of tolerance to nuclear autoantigens.
However, in contrast to the serological data, the histological
assessment of the kidneys showed evidence of markedly
increased glomerulonephritis in the C57BL/6.Apcs
 /  com-
pared to both control groups (Figure 9), suggesting that the
lack of Apcs, when combined with other C57BL/6 suscepti-
bility alleles, can induce the development of severe renal
damage.
Discussion
There is accumulating evidence that background genes may
inﬂuence the expression of autoimmunity in gene-targeted
mice. Here we report what is to our knowledge the ﬁrst
systematic study that has examined this in the 129 and C57BL/
6 mouse strains, widely used for gene targeting. Our results
demonstrate interacting loci between 129 and C57BL/6 mice
that can cause the expression of a powerful autoimmune
phenotype in these animals, in the absence of any gene-
targeted mutations. We also developed a congenic mouse
strain bearing a portion of 129 Chromosome 1 on a C57BL/6
background and showed that this wild-type congenic line
expressed striking anti-nuclear autoimmunity. By comparing
this Chromosome 1 congenic strain with matched congenic
mice lacking the Apcs gene, we demonstrated that serum
amyloid P component deﬁciency inﬂuences the severity of
glomerulonephritis, but is not the prime mover in the
induction of anti-nuclear autoimmunity, contrary to our
own original interpretation of our data (Bickerstaff et al.
1999). The same consideration applies to other genes located
Figure 6. Auto-Ab Profiles
(A) ANA titres in the (129 3 C57BL/
6)F2.Apcs
 /  mice and (129 3 C57BL/6)F2
at 1 y of age. A small circle represents
one mouse; a large circle, a variable
number of animals, as indicated in
parentheses. Serum samples were ti-
trated to endpoint.
(B) ANA titres in the (129 3 C57BL/
6)F2.Apcs
 /  mice and a selected number
of wild-type (129 3 C57BL/6)F2 animals
carrying the Chromosome 1 region
between D1Mit105 and D1Mit223 (80–
106 cM) of 129 origin. The symbols are as
in (A).
(C and D) Anti-chromatin Ab levels
expressed in AEUs related to a standard
positive sample, which was assigned a
value of 100 AEU. The comparison is
between the same groups of mice as in
(A) and (B), respectively. The symbols are
as in (A).
DOI: 10.1371/journal.pbio.0020243.g006
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Gene-Targeted Mice and Autoimmunityin the same Chromosome 1 region that have been implicated
in the development of SLE when inactivated by gene-
targeting in 129 embryonic stem cells and then backcrossed
onto a pure genetic background (Bolland and Ravetch 2000;
Miwa et al. 2002; Wu et al. 2002). For each, there has to be a
question as to whether the anti-nuclear autoimmunity is due
to the gene-targeted mutant gene or to the normal 129 genes
expressed in the same region as the targeted gene.
The inﬂuence of background genes on the development of
spontaneous autoimmune disease is well known, especially
with respect to the lpr and Yaa disease-susceptibility genes. In
MRL/Mp mice, the presence of the lpr gene accelerates the
development of high level and broad-spectrum auto-Ab
production and lethal glomerulonephritis, in addition to
marked lymphoproliferative disease. In contrast, homozygos-
ity of the lpr gene in other strains such as C57BL/6, AKR, LG/J,
and C3H leads only to auto-Ab production (Izui et al. 1984).
Similarly, the Y-chromosome-linked Yaa gene in BXSB and
MRL/Mp males enhances the rapid development of auto-Abs
and glomerulonephritis (Izui et al. 1988; Merino et al. 1989).
However, in the C57BL/6 background, the Yaa gene does not
lead to an autoimmune phenotype (Izui et al. 1988). Not
surprisingly, important effects of the genetic background on
the expression of autoimmunity have also been reported in
gene-targeted mice (Bolland and Ravetch 2000; Santiago-
Raber et al. 2001; Mitchell et al. 2002). Thus, SLE exists as a
complex-trait disorder in which speciﬁc combinations of
susceptibility alleles are required for the expression of the
full phenotype.
Through the use of microsatellite marker maps, the
identiﬁcation of murine SLE susceptibility intervals in
experimental crosses has been made possible. These mapping
studies have shown that the disease expression in relation to
the inheritance of the different alleles followed a threshold
liability pattern in which a positive phenotype depended
upon the presence of multiple discrete susceptibility loci with
no single locus being a prerequisite factor. We have employed
the same approach to analyse the genetic basis of disease
inheritance in the (129 3 C57BL/6) hybrid strain, the most
common genetic background in gene-targeted mice.
Although spontaneous autoimmunity has not been docu-
mented in either of the pure 129 or C57BL/6 strains, a
spontaneous lupus-like phenotype has been described in (129
3C57BL/6) hybrid strains (Obata et al. 1979; Botto et al. 1998;
Bickerstaff et al. 1999; Santiago-Raber et al. 2001), suggesting
that the predisposition in these hybrid mice may arise as a
result of the interaction between speciﬁc combinations of
alleles inherited from both the 129 and C57BL/6 parental
strains.
This was conﬁrmed by the mapping study reported here.
We showed that there are multiple genetic loci contributing
to the disease and these are derived from both 129 and
C57BL/6 mice. We demonstrated that a 129-derived segment
of Chromosome 1 was strongly linked to the expression of
auto-Abs. This region is probably capable of causing the
initiation of a humoral autoimmune response to nuclear
antigens; however, this response does not occur in the
absence of C57BL/6 genes. In support of this, we identiﬁed
a C57BL/6 segment on Chromosome 3, which may interact
with the 129 genes on Chromosome 1 to mediate the loss of
tolerance. Interestingly, although the C57BL/6 SLE-suscepti-
bility region on Chromosome 3 is novel, disease-modifying
alleles derived from C57BL/10 and C57BL/6 strains have been
mapped to a portion of Chromosome 3 close to the region
identiﬁed in this study (Morel et al. 1999; Haywood et al.
2000). Furthermore, the region on Chromosome 7 associated
with the development of lupus nephritis has been linked to
the same trait in other murine models of SLE (Santiago et al.
1998; Morel et al. 1999; Xie et al. 2002), suggesting the
possibility of shared susceptibility loci.
Taken together our results suggest a complex genetic
contribution from the (129 3 C57BL/6) hybrid background
genome, with both enhancing as well as inhibitory loci from
the 129 mouse, in addition to genes promoting autoimmunity
from the C57BL/6 mice. The impact that these interacting
loci may have on the lupus-like disease present in several
gene-targeted animals was further assessed by comparing
Apcs
 /  mice with Chromosome 1 genetically matched con-
trols.
Figure 7. Interval Mapping Scans Showing QTL on Chromosome 3 with
ANA, Anti-Chromatin, and Anti-ssDNA Abs
See Table 3 for additional details. Centimorgan positions were
deduced by interval mapping, anchoring marker locations to data
from http://www.informatics.jax.org. Dotted lines indicate the thresh-
old over which linkage was considered suggestive, the dashed line
indicate the threshold over which linkage was considered signiﬁcant,
and dotted/dashed lines indicate highly signiﬁcant linkage, as deﬁned
in Materials and Methods.
DOI: 10.1371/journal.pbio.0020243.g007
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Gene-Targeted Mice and AutoimmunityIn the context of SLE susceptibility, one of the most
consistently mapped non-MHC regions of the mouse genome
is the telomeric Chromosome 1 segment, where several
disease loci, designated Sle1 (Morel et al. 2001), Nba2 (Drake
et al. 1995; Rozzo et al. 1996; Vyse et al. 1997), and Bxs3
(Hogarth et al. 1998), have been mapped in lupus-prone
strains. Moreover, this region of mouse Chromosome 1 is
orthologous to a region on human Chromosome 1q22–1q25,
which has also been linked with human SLE (Moser et al.
1998).
The Apcs gene is one of the candidate genes known to lie
within this region. The human serum amyloid P component
binds avidly to DNA, chromatin, and apoptotic cells in
physiological conditions in vitro (Pepys 1974; Pepys and
Butler 1987; Butler et al. 1990) and also to exposed chromatin
and apoptotic cells in vivo (Hintner et al. 1988; Breathnach et
al. 1989; Familian et al. 2001). We have previously reported
that (129 3 C57BL/6).Apcs
 /  mice spontaneously produce a
wide range of ANAs and develop signiﬁcant immune complex
glomerulonephritis (Bickerstaff et al. 1999). On the basis of
these observations, it was postulated that Apcs, by altering the
clearance of chromatin, contributes to the pathogenesis of
SLE. However, in this study we found that only ANA and anti-
chromatin Ab levels were signiﬁcantly increased in the (1293
C57BL/6)F2.Apcs
 /  mice. A possible explanation for this
discrepancy may lie in the fact that the Apcs
 /  mice analysed
in the original study were generated from a limited number
of founders and that this may have caused a nonrandom
inheritance of the loci from the parental strains. Further-
more, the whole-genome analysis identiﬁed the 129 region
surrounding the Apcs gene as the main locus contributing to
the development of ANA and anti-chromatin Ab. In agree-
ment with this, when we carried out a selective comparison
between the (129 3 C57BL/6)F2.Apcs
 /  mice and Chromo-
some 1 genetically matched controls, we failed to detect any
signiﬁcant difference in the levels of these two auto-Abs.
These ﬁndings, taken together, indicated that the phenotype
associated with Apcs deﬁciency was caused by the presence of
unaltered 129 genes from the telomeric region of Chromo-
Figure 8. Auto-Ab Profiles
(A) ANA titres in C57BL/6 mice, C57BL/
6.Apcs
 /  mice, and C57BL/
6.129(D1Mit105–223) congenic mice at
1 y of age. Small symbols represent one
mouse; large symbols, a variable number
of animals as indicated in parentheses.
Serum sample were titrated to endpoint.
(B and C) Anti-ssDNA (B) and anti-
chromatin (C) Ab levels in the same
cohorts of mice as in (A). The Ab levels
are expressed in AEUs related to a
standard positive sample, which was
assigned a value of 100 AEU.
(D) Anti-dsDNA Ab levels. Serum sam-
ples were screened at 1:20. Samples that
were positive were titrated to endpoint.
The symbols are as in (A).
DOI: 10.1371/journal.pbio.0020243.g008
Figure 9. Renal Histological Assessment
C57BL/6 mice, C57BL/6.Apcs
 /  mice, and C57BL/6.129(D1Mit105–
223) congenic mice were sacriﬁced at 1 y of age to obtain age-
matched autopsy specimens. Bouin’s ﬁxed kidney sections were
scored blinded for glomerulonephritis. Glomerulonephritis was
graded on a 0–3 scale (see Materials and Methods for details).
DOI: 10.1371/journal.pbio.0020243.g009
PLoS Biology | www.plosbiology.org August 2004 | Volume 2 | Issue 8 | e243 1088
Gene-Targeted Mice and Autoimmunitysome 1 operating in the C57BL/6 genomic background.
Strong supportive evidence for this was provided by the
analysis of the C57BL/6 mice congenic for this 129 region.
The generation and analysis of congenic strains have
successfully been used to dissect the contribution of
individual susceptibility alleles to a multigenic trait such as
SLE. We adopted the same strategy to investigate the relative
contribution of the 129 Chromosome 1 segment and the Apcs
gene to each disease trait. Using this approach, we demon-
strated that the 129 interval on distal Chromosome 1, when
transferred onto the C57BL/6 genome, a combination
commonly created by backcrossing onto C57BL/6 a mutated
gene located in that chromosomal region, was sufﬁcient to
mediate the production of auto-Abs. In this context, it is of
note that several strains of mice with targeted mutations of
genes encoded in this region have been reported to express a
lupus-like illness, including mice lacking FccRIIB (Bolland
and Ravetch 2000), complement receptors (CR1/2) (Prodeus
et al. 1998; Wu et al. 2002), and decay-accelerating factor
(CD55) (Miwa et al. 2002). In each case, the autoimmune
phenotype was described in mice in which the null mutation
was generated in 129 embryonic stem cells and then
backcrossed to the C57BL/6 or another genetic background.
Thus, in view of our ﬁndings, one may postulate that in each
of these murine models of SLE, the effects of the targeted null
gene were irrelevant. Similar conclusions may apply to other
gene-targeted animals carrying mutations of genes mapped in
the 129-derived susceptibility allele on Chromosome 7
(O’Keefe et al. 1996, 1999).
The expression of anti-nuclear autoimmunity was identical
comparing the congenic with the Apcs
 /  mice. The only
difference in phenotype between these mice was in the
expression of glomerulonephritis, which was more pro-
nounced in the Apcs
 /  mice compared with the congenic
mice. Although these ﬁndings demonstrate that Apcs is not
implicated in the processing of autoantigens, as it had
previously been suggested, they indicate that Apcs might still
play an important protective role in lupus nephritis. In
support of this, the expression of the human C-reactive
protein, an acute-phase protein closely related to Apcs, has
been shown to delay the onset and severity of lupus nephritis
in the NZB/W strain by preventing the deposition of immune
complexes in the renal cortex (Szalai et al. 2003). Consistent
with this, a polymorphism associated with reduced basal level
of C-reactive protein has been reported to be linked to SLE in
humans (Russell et al. 2004). However, as the congenic mice
and the Apcs
 /  mice carried similar but not identical 129
regions on Chromosome 1, an alternative explanation for our
ﬁndings may still lay in the numerous and complex
synergistic and counteractive interactions between 129 and
C57BL/6 genes involved in self-tolerance and end organ
damage. Thus, whilst the lack of lupus nephritis in the
congenic mice is consistent with the need for multiple
susceptibility genes for the full expression of lupus, further
studies will be required to fully elucidate the role of Apcsi n
the pathogenesis of renal damage.
In summary, our ﬁndings demonstrate the impact of
epistatic interactions between 129 and C57BL/6 genomes on
the development of SLE and illustrate how these background
gene effects may lead to incorrect interpretations when
analysing the autoimmune phenotype of speciﬁc genetic
disruptions.
Materials and Methods
Mice. All the mice were females. Wild-type C57BL/6 and 129/Sv
(129S6, according to the revised nomenclature) were bred and
maintained in the animal care facility at Imperial College, London,
United Kingdom. (129 3 C57BL/6)F1 mice were generated by
intercrossing the two wild-type strains and (129 3 C57BL/6)F2 mice
by interbreeding the (129 3 C57BL/6)F1 mice. The Apcs
 / mice were
generated as previously reported (Botto et al. 1997), and the (129 3
C57BL/6)F2.Apcs
 /  mice were generated by intercrossing Apcs
 /  mice
on the 129 genetic background with Apcs / animals backcrossed onto
C57BL/6 for ten generations. A total of 141 (129 3 C57BL/6)F2 and
158 (129 3 C57BL/6)F2.Apcs
 /  female mice were produced and
monitored for 1 y. Wild-type congenic C57BL/6.129(D1Mit105–223)
mice were generated by backcrossing the 129 interval between
microsatellites D1Mit105 and D1Mit223 (80 cM to 106 cM) onto the
C57BL/6 strain. Inherited 129 regions were mapped with micro-
satellite markers polymorphic between 129 and C57BL/6 mice (see
below). After seven generations of backcrossing, siblings were
intercrossed to generate C57BL/6.129(D1Mit105–223) congenic mice
homozygous for the 129 Chromosome 1 interval. Inside 129 markers
at positions 81.6 cM (D1Mit159) and 105 cM (D1Mit17), respectively,
and an outside C57BL/6 marker at position 74.3cM (D1Mit159) were
used to further deﬁne the interval. In the C57BL/6.Apcs
 /  mice
(backcrossed onto C57BL/6 for ten generations), the 129 genome
around the Apcs locus was mapped as a segment from 87.9 cM
(D1Mit15) to 105 cM (D1Mit17). In this analysis, the inside 129
markers were at positions 93 cM (D1Mit36) and 99.7 cM (D1Mit115)
and the outside C57BL/6 markers at positions 81.6 cM (D1Mit159) and
106 cM (D1Mit223). Along with 28 C57BL/6.Apcs / mice and 30
C57BL/6 wild-type animals, 26 C57BL/6.129(D1Mit105–223) female
mice
 / were followed up to 1 y of age. Animals were maintained in
speciﬁc pathogen-free conditions. All animal procedures were in
accordance with institutional guidelines.
Serological analyses. Sera, collected at 6 and 12 mo of age, were
assayed for the presence of auto-Abs. Levels of IgG ANA were sought
by indirect immunoﬂuorescence using Hep-2 cells, and anti-dsDNA
Abs were detected by indirect immunoﬂuorescence on Crithidia
luciliae as previously described (Mitchell et al. 2002). Serum samples
were screened at a 1:80 (ANA) or 1:20 (anti-dsDNA) dilution and the
positive samples titrated to endpoint. Abs to ssDNA and anti-
chromatin were measured by ELISA, as previously described (Mitchell
et al. 2002). Samples were screened at a 1:100 dilution, and the results
were expressed in arbitrary ELISA units (AEUs) relative to a standard
positive sample (derived from an MRL/Mp.lpr/lpr mouse), which was
assigned a value of 100. For interplate comparison, serial dilutions of
a positive control serum sample were included on each plate. Apcs
levels were assessed by ELISA using sheep anti-mouse Apcs and rabbit
anti-mouse Apcs Abs (Calbiochem, Nottigham, United Kingdom).
Samples were screened at a 1:3,000 dilution, and the results were
expressed in milligrams per liters, referring to a standard curve
derived from an acute-phase serum with a known concentration of
Apcs (Calbiochem). Apcs
 /  mouse serum was included as a negative
control.
Histological analysis. All the mice, except the few that died before
the end of the experiment, were sacriﬁced at 1 y of age, and kidney
portions were ﬁxed in Bouin’s solution and parafﬁn embedded, and
sections were stained with periodic acid–Schiff reagent. Glomerular
histology was graded in a blinded fashion as follows: grade 0, normal;
grade 1, hypercellularity involving greater than 50% of the
glomerular tuft in 25%–50% of glomeruli; grade 2, hypercellularity
involving greater than 50% of the glomerular tuft in 50%–75% of
glomeruli; grade 3, glomerular hypercellularity in greater than 75%
of glomeruli or crescents in greater than 25% of glomeruli.
Statistical analysis. Non-parametric data are expressed as median
with range of values in parentheses. All statistics were calculated
using GraphPad PrismTM version 3.0 for Windows (GraphPad
Software, San Diego, California, United States). Non-parametric tests
were applied throughout, with differences being considered signiﬁ-
cant for p values , 0.05. The Mann–Whitney test was used for
comparison of two groups, whilst for analysis of three groups the
Kruskal–Wallis test with Dunn’s multiple comparison test was used.
Genotypic analysis. Genotyping was carried out by PCR of genomic
DNA using 143 polymorphic markers (list available on request)
distributed throughout all 19 autosomes. PCRs were performed using
standard reagents containing 1.5 mM MgCl2 and 0.4 lM primers.
Microsatellite markers were screened for size polymorphisms
between 129 and C57BL/6 mice. Only primers with differences
detectable on ethidium bromide-stained agarose gels or on SDS-
polyacrylamide gels were used.
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Gene-Targeted Mice and AutoimmunityLinkage analysis. The QTL program MAPMANAGER.QTL (ftp://
mcbio.med.buffalo.edu/pub/MapMgr/) was used, and the two exper-
imental groups were examined independently. Only data from mice
at 12 mo of age were analysed. Log transformations of auto-Abs levels
resulted in more normalised distribution and were used in QTL
mapping. LOD thresholds for suggestive and signiﬁcant linkages were
determined by using a cohort- and trait-speciﬁc permutation test
(1,000 permutations). The average threshold for suggestive, signiﬁ-
cant, and highly signiﬁcant linkages were LOD   2.1 (p   7.8310
 3),
LOD   3.6 (p   2.4310
 4), and LOD   5(p   1310
 5), respectively
(Manly and Olson 1999).
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